Literature DB >> 27143047

Elevated AQP1 Expression Is Associated With Unfavorable Oncologic Outcome in Patients With Hilar Cholangiocarcinoma.

Chunxiang Li1, Xiaofu Li2, Linfeng Wu3, Zheng Jiang4,5.   

Abstract

BACKGROUND: Hilar cholangiocarcinomas are malignant tumors with a poor prognosis. An early prediction of prognosis for patients may help us determine treatment strategies. Aquaporin 1 is a cell membrane channel involved in water transport, cell motility, and proliferation. Increasing evidences showed that aquaporin 1 played a role in tumor prognosis and diagnosis. The purpose of this study is to evaluate the role of aquaporin 1 in hilar cholangiocarcinoma.
METHODS: Here, we analyzed messenger RNA expression data of genes function as bile secretion in a data set of 169 samples using the R2 bioinformatic platform ( http://r2.amc.nl ). Quantitative polymerase chain reaction was performed to verify the gene expression in 17 hilar cholangiocarcinoma samples. Immunohistochemistry was also performed in a series of specimens from 62 hilar cholangiocarcinoma tissues, and its clinical significance was assessed by clinical correlation and Kaplan-Meier analyses.
RESULTS: All data were analyzed using the R2 web application, aquaporin 1 was selected for further analysis. The significant expression variation of aquaporin 1 among 17 cases with cholangiocarcinoma was also found using quantitative polymerase chain reaction. The expression level of aquaporin 1 protein significantly correlated with tumor-node-metastasis stage ( P = .002) and overall survival time ( P = .010). Higher aquaporin 1 expression indicated poor prognostic outcomes ( P <.05, log-rank test). Multivariate analysis also showed strong aquaporin 1 protein expression was an independent adverse prognosticator in hilar cholangiocarcinoma ( P = .002).
CONCLUSION: This study highlighted the prognostic value of aquaporin 1 in hilar cholangiocarcinoma. Strong aquaporin 1 expression predicts poor survival, regardless of pathological features. Immunohistochemical detection of aquaporin 1, as a prognostic marker, may contribute to predicting clinical outcome for patients with hilar cholangiocarcinoma.

Entities:  

Keywords:  AQP1; hilar cholangiocarcinoma; prognosis

Mesh:

Substances:

Year:  2016        PMID: 27143047      PMCID: PMC5616059          DOI: 10.1177/1533034616646288

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  31 in total

1.  Aquaporin 1 is overexpressed in lung cancer and stimulates NIH-3T3 cell proliferation and anchorage-independent growth.

Authors:  Mohammad Obaidul Hoque; Jean-Charles Soria; Janghee Woo; Taekyeol Lee; Juna Lee; Se Jin Jang; Sunil Upadhyay; Barry Trink; Constance Monitto; Chantal Desmaze; Li Mao; David Sidransky; Chulso Moon
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

2.  Aquaporin 1 is an independent prognostic factor in pleural malignant mesothelioma.

Authors:  Steven Chuan-Hao Kao; Nicola Armstrong; Bridget Condon; Kim Griggs; Brian McCaughan; Sarah Maltby; Alan Wilson; Douglas W Henderson; Sonja Klebe
Journal:  Cancer       Date:  2011-10-21       Impact factor: 6.860

3.  Diagnostic significance of aquaporin-1 in liver tumors.

Authors:  Peter R Mazal; Martin Susani; Fritz Wrba; Andrea Haitel
Journal:  Hum Pathol       Date:  2005-11       Impact factor: 3.466

4.  Aquaporin-1 facilitates epithelial cell migration in kidney proximal tubule.

Authors:  Mariko Hara-Chikuma; A S Verkman
Journal:  J Am Soc Nephrol       Date:  2005-11-30       Impact factor: 10.121

5.  [Evaluation of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma from intrahepatic cholangiocarcinoma].

Authors:  Hui Dong; Wen-Ling Cong; Zhong-Zheng Zhu; Bin Wang; Zhi-Hong Xian; Hua Yu
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2008-09

6.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

Review 7.  Aquaporins--new players in cancer biology.

Authors:  A S Verkman; Mariko Hara-Chikuma; Marios C Papadopoulos
Journal:  J Mol Med (Berl)       Date:  2008-03-01       Impact factor: 4.599

8.  Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.

Authors:  Andrea Tannapfel; Florian Sommerer; Markus Benicke; Lars Weinans; Alexander Katalinic; Felix Geissler; Dirk Uhlmann; Johann Hauss; Christian Wittekind
Journal:  J Pathol       Date:  2002-08       Impact factor: 7.996

9.  Expression of aquaporin-1 is a poor prognostic factor for stage II and III colon cancer.

Authors:  Toru Yoshida; Shozo Hojo; Shinichi Sekine; Shigeaki Sawada; Tomoyuki Okumura; Takuya Nagata; Yutaka Shimada; Kazuhiro Tsukada
Journal:  Mol Clin Oncol       Date:  2013-08-05

10.  Hypomethylation-associated up-regulation of TCF3 expression and recurrence in stage II and III colorectal cancer.

Authors:  Chunxiang Li; Sanjun Cai; Xishan Wang; Zheng Jiang
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

View more
  3 in total

1.  YBX1 knockdown induces renal cell carcinoma cell apoptosis via Kindlin-2.

Authors:  Qiqi Cui; Chao Wang; Shuang Liu; Runxuan Du; Shaoping Tian; Ruibing Chen; Hua Geng; Saravanan Subramanian; Yuanjie Niu; Yong Wang; Dan Yue
Journal:  Cell Cycle       Date:  2021-10-28       Impact factor: 4.534

Review 2.  Role of Aquaporin 1 Signalling in Cancer Development and Progression.

Authors:  Yoko Tomita; Hilary Dorward; Andrea J Yool; Eric Smith; Amanda R Townsend; Timothy J Price; Jennifer E Hardingham
Journal:  Int J Mol Sci       Date:  2017-01-29       Impact factor: 5.923

3.  Cell division cycle associated 5 promotes colorectal cancer progression by activating the ERK signaling pathway.

Authors:  Aling Shen; Liya Liu; Hongwei Chen; Fei Qi; Yue Huang; Jiumao Lin; Thomas Joseph Sferra; Senthilkumar Sankararaman; Lihui Wei; Jianfeng Chu; Youqin Chen; Jun Peng
Journal:  Oncogenesis       Date:  2019-02-26       Impact factor: 7.485

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.